Similarly, lncRNA-NUTF2P3–001 has been suggested to act as a ‘sponge’ that inhibits miR-3923 that targeted KRAS, a critical driver in pancreatic cancer tumorigenesis [56]. The gene discussed is NUTF2P3; the disease is familial pancreatic carcinoma.